Insider Transactions in Q2 2025 at Thermo Fisher Scientific Inc. (TMO)
Insider Transaction List (Q2 2025)
Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
---|---|---|---|---|---|
Jun 02
2025
|
Thomas B Shropshire Jr. SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
5,417
+50.0%
|
-
|
May 21
2025
|
Nelson Chai Director |
BUY
Grant, award, or other acquisition
|
Direct |
565
+3.67%
|
-
|
May 21
2025
|
James C Mullen Director |
BUY
Grant, award, or other acquisition
|
Direct |
565
+14.27%
|
-
|
May 21
2025
|
R. Alexandra Keith Director |
BUY
Grant, award, or other acquisition
|
Direct |
565
+21.18%
|
-
|
May 21
2025
|
C Martin Harris Director |
BUY
Grant, award, or other acquisition
|
Direct |
565
+5.89%
|
-
|
May 21
2025
|
Ruby R Chandy Director |
BUY
Grant, award, or other acquisition
|
Direct |
565
+16.01%
|
-
|
May 21
2025
|
Jennifer M Johnson Director |
BUY
Grant, award, or other acquisition
|
Direct |
565
+38.46%
|
-
|
May 21
2025
|
Karen S Lynch Director |
BUY
Grant, award, or other acquisition
|
Direct |
565
+46.12%
|
-
|
May 21
2025
|
Debora L Spar Director |
BUY
Grant, award, or other acquisition
|
Direct |
565
+21.11%
|
-
|
May 21
2025
|
Dion J Weisler Director |
BUY
Grant, award, or other acquisition
|
Direct |
565
+10.1%
|
-
|
May 21
2025
|
Dion J Weisler Director |
SELL
Payment of exercise price or tax liability
|
Direct |
53
-1.17%
|
$21,094
$398.28 P/Share
|
May 21
2025
|
Tyler Jacks Director |
BUY
Grant, award, or other acquisition
|
Direct |
565
+5.93%
|
-
|
May 21
2025
|
Scott M Sperling Director |
BUY
Grant, award, or other acquisition
|
Direct |
565
+0.76%
|
-
|
May 12
2025
|
Gianluca Pettiti Executive Vice President |
SELL
Open market or private sale
|
Direct |
400
-1.73%
|
$164,400
$411.11 P/Share
|
Apr 28
2025
|
Gianluca Pettiti Executive Vice President |
SELL
Open market or private sale
|
Direct |
300
-1.28%
|
$128,700
$429.93 P/Share
|